Industry Trends

Transcarent paying $621M to acquire health benefits navigator Accolade 

by

Transcarent has announced plans to acquire Accolade for $621 million, marking a significant step toward its mission of delivering affordable and high-quality healthcare solutions. The acquisition will combine Transcarent’s innovative WayFinding and care solutions with Accolade’s personalized healthcare platform, creating a unified and comprehensive healthcare experience for users.  This collaboration aims to enhance accessibility to … Read more

Pfizer picks Triana Biomedicines to find Molecular Glues for Cancer

by

US pharmaceutical giant Pfizer announced a groundbreaking collaboration with Triana Biomedicines to develop Molecular Glue Degraders. The partnership aims to create multiple advanced therapies, including cancer. The collaboration is seen as a significant step forward in developing advanced medical treatments that can address challenging disease targets.  Targeted protein degradation is a novel and fast-growing segment. … Read more

OncoC4 merged with AcroImmune

by

OncoC4, a biopharmaceutical firm in its final phases of developing advanced cancer therapies, is merging with AcroImmune, a developer of immunotherapies for malignant tumors and inflammatory diseases. The merger produces first- and best-in-class immunotherapies. Drs. Yang Liu and Pan Zheng co-founded OncoC4 and AcroImmune, and they share a common shareholder base. The combined firm was … Read more

CorroHealth Acquired Revenue Cycle Management Business from Navient

by

CorroHealth has finalized its acquisition of the healthcare revenue cycle management (RCM) business from Navient’s Xtend Healthcare, significantly expanding its capabilities in revenue cycle management consultancy and technology. This strategic move enhances CorroHealth’s RCM offerings, introducing multichannel patient engagement capabilities that were previously missing from its suite of services. By adding these capabilities, CorroHealth strengthens … Read more

NanoVation Therapeutics Partners with Novo Nordisk to Develop Genetic Medicines for Cardiometabolic and Rare Diseases

by

Overview of the Deal:NanoVation Therapeutics has entered into a multi-year partnership with Novo Nordisk to develop cutting-edge genetic medicines that target cardiometabolic and rare diseases. Announced on September 18, 2024, this collaboration will leverage NanoVation’s long-circulating lipid nanoparticle (lcLNP™) technology, which enables RNA delivery to cells outside the liver, combined with Novo Nordisk’s expertise in … Read more

Axcelead DDP and Eli Lilly Partner for Drug Discovery Programs

by

Deal OverviewAxcelead Drug Discovery Partners (Axcelead DDP), a Japanese drug discovery company, has entered into a strategic research and collaboration agreement with Eli Lilly and Company (Lilly), a global pharmaceutical leader. Announced on September 5, 2024, the collaboration aims to leverage Axcelead DDP’s innovative drug discovery technologies to support multiple drug discovery programs for Lilly. … Read more

Organon Expands Dermatology Portfolio with Acquisition of Dermavant and Its VTAMA Cream

by

Organon, a global healthcare company dedicated to improving the health of women throughout their lives, has announced the acquisition of Dermavant Sciences Ltd., a dermatology-focused subsidiary of Roivant Sciences. This acquisition will broaden Organon’s dermatology capabilities in the U.S. and beyond. The move aligns with Organon’s long-term strategy of expanding into therapeutic areas with high … Read more

Kalsi Insurance Partners with Integrity to Provide Enhanced Insurance Solutions to Underserved Communities

by

Integrity Marketing Group has announced a partnership with Kalsi Insurance Agency to provide better life and health insurance options to underserved communities. Through this collaboration, Kalsi Insurance agents will gain access to Integrity’s cutting-edge technology platform, allowing them to better serve diverse populations such as immigrants and seniors by simplifying Medicare complexities. Kalsi Insurance, led … Read more

EQT to Acquire GeBBS Healthcare Solutions

by

EQT Private Capital Asia has announced its agreement to acquire a controlling interest in GeBBS Healthcare Solutions from ChrysCapital. GeBBS specializes in revenue cycle management, health information management (HIM), and medical billing services, helping U.S.-based healthcare providers improve their financial performance through optimized revenue cycle processes and accurate coding and billing practices. Founded in 2005, … Read more

A. Menarini Diagnostics and Nucleix Form Strategic Partnership for Non-Invasive Bladder Cancer Test in Europe

by

A. Menarini Diagnostics and Nucleix have announced a strategic commercial agreement to exclusively market the Bladder EpiCheck® test in Europe. This non-invasive, CE-marked urine test is designed to detect and monitor bladder cancer and upper tract urothelial carcinoma (UTUC), providing an alternative to invasive cystoscopy. The partnership was revealed at the 36th European Congress of … Read more